MSN Laboratories Pvt. Ltd.

A US federal district court in New Jersey has issued a preliminary injunction on the balance of the merits against MSN Laboratories’ “strikingly similar” ‘Novadoz’ generic version of Novartis’ Entrest

The US Association for Accessible Medicines has underlined that the “pharmaceutical industry is watching this case closely,” as it moved to file in support of MSN Laboratories’ bid to overturn the rec

As MSN Laboratories continues to battle hard in court to accelerate the launch of its US generic version of Novartis’ Entresto (sacubitril/valsartan), the Swiss originator has told investors that “we

A federal court ruled in favor of the government after Vanda Pharmaceuticals alleged improper disclosure of trade secrets, as well as confidential commercial and proprietary information, to generics